Development and Validation of Three Novel UV Spectrophotometric Methods for Simultaneous Estimation of Efonidipine Hydrochloride Ethanolate and Telmisartan in Their Synthetic Mixture and Its Comparison Using ANOVA

Efonidipine hydrochloride ethanolate and telmisartan combination is used for to treat hypertension treatment and under clinical phase ۴ study. It is necessary to develop suitable quality control methods for rapid and accurate determination of these drugs. Three simple, accurate, sensitive, precise and economical UV spectrophotometric methods (A, B &, and C) have been developed for simultaneous estimation of efonidipine hydrochloride ethanolate and telmisartan in their synthetic mixture. Method (A) is based on the first order derivative spectrophotometric method at zero crossing wavelength. In this method the zero crossing zero-crossing point of efonidipine hydrochloride ethanolate is ۳۲۶ nm and for telmisartan is ۲۷۲ nm. The linearity was obtained in the concentration range of ۸-۲۰ μg/ml for efonidipine hydrochloride ethanolate and ۱۶-۴۰ μg/ml for telmisartan using methanol as a solvent. Method (B) is based on absorbance correction method, method; it was performed at ۳۴۷ nm for efonidipine hHydrochloride ethanolate and at ۲۹۶ nm for telmisartan. Method (C) is based on dual wavelength method developed using absorbance difference at ۲۴۲.۵ nm and ۲۵۷.۵ nm for efonidipine hydrochloride ethanolate and ۲۴۴.۵ nm and ۲۸۷ nm for telmisartan. The accuracy and precision of the methods were determined assessed and validated statistically. All the methods showed revealed good reproducibility and recovery. The three methods were compared using one way ANOVA. All methods were found to be rapid, specific, precise and accurate and these methods require no preliminary separation and found no interferences from the tablet excipients so it can be used for routine analysis of both drugs in quality control laboratories.

کلیدواژه ها:

Efonidipine Hydrochloride Ethanolate ، Telmisartan ، ANOVA ، UV ، Spectrophotometric methods ، Antihypertensive